报道了带有桥接双吡啶基辅助配体的铜 ( I ) 配合物家族的合成和表征,突出了桥接性质如何影响该家族内的光致和电致发光行为。特别是,鏻桥导致铜(I)配合物具有良好的电化学稳定性和高离子电导率,以及与其他配合物相比明显的蓝色到橙色发光转变。这导致高性能发光电化学电池在大约10 mJ 的稳定性。40 cd m -2比其他复合体高一个数量级。总的来说,这项工作揭示了双吡啶基辅助配体的桥接性质对光物理特征、成膜以及最终器件性能的关键作用。
An object of the present invention is to provide a method for efficiently chemically synthesizing biomolecules including a nucleotide (nucleic acid), a peptide (protein), or a sugar chain, as representative examples. The present invention provides a method of solid-phase synthesis of sugar chain(s) for synthesizing multiple types of sugar chains in at least one sugar chain synthesis reaction system comprising multiple types of monosaccharide units, which is characterized in that it comprises changing the temperature in the sugar chain synthesis reaction system depending on the temperature rising rate that has been determined based on a decrease in side reaction(s) in the reaction system as an indicator.
Synthesis of Symmetrical Diaryl Sulfone by Homocoupling of Sodium Arylsulfinate
作者:Yao Peng
DOI:10.3184/174751914x13946336636551
日期:2014.5
An efficient practical homocoupling reaction of sodium arylsulfinate promoted by Cu(II) is reported whereby symmetricaldiaryl sulfone derivatives are obtained with high selectivity and reactivity by intermolecular cross-coupling. This homocoupling reaction is tolerant to many functional groups and proceeds under mild conditions.
[EN] 1,2,3-TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PRPPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO SUCH AS DIABETES AND HYPERGLYCEMIA<br/>[FR] DERIVES ARYLES ET HETEROARYLES TRI-SUBSTITUES EN POSITION 1,2,3 EN TANT QUE MODULATEURS DE METABOLISME ET PROPHYLAXIE ET TRAITEMENT DE TROUBLES LIES AU METABOLISME
申请人:ARENA PHARM INC
公开号:WO2004065380A1
公开(公告)日:2004-08-05
The present invention relates to certain 1,2,3-trisubstituted aryl and heteroaryl derivatives of Fomula (Ia) that are modulators of metabolism. Accordingly, compounds of the present invention are useful in the prophylaxis or treatment of metabolic disorders and complications thereof, such as, diabetes and obesity.
Towards rainbow photo/electro-luminescence in copper(<scp>i</scp>) complexes with the versatile bridged bis-pyridyl ancillary ligand
作者:Gilbert Umuhire Mahoro、Elisa Fresta、Margaux Elie、Davide di Nasso、Qi Zhang、Jean-François Lohier、Jean-Luc Renaud、Mathieu Linares、Reinhold Wannemacher、Juan Cabanillas-Gonzalez、Rubén D. Costa、Sylvain Gaillard
DOI:10.1039/d1dt01689j
日期:——
synthesis and characterization of a family of copper(I) complexes bearing a bridged bis-pyridyl ancillary ligand is reported, highlighting how the bridge nature impacts the photo- and electro-luminescent behaviours within the family. In particular, the phosphonium bridge led to copper(I) complexes featuring good electrochemical stability and high ionic conductivity, as well as a stark blue-to-orange luminescence
报道了带有桥接双吡啶基辅助配体的铜 ( I ) 配合物家族的合成和表征,突出了桥接性质如何影响该家族内的光致和电致发光行为。特别是,鏻桥导致铜(I)配合物具有良好的电化学稳定性和高离子电导率,以及与其他配合物相比明显的蓝色到橙色发光转变。这导致高性能发光电化学电池在大约10 mJ 的稳定性。40 cd m -2比其他复合体高一个数量级。总的来说,这项工作揭示了双吡啶基辅助配体的桥接性质对光物理特征、成膜以及最终器件性能的关键作用。
[EN] HETEROARYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER<br/>[FR] PYRIDINES À SUBSTITUTION HÉTÉROARYLSULFONYLE ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER
申请人:OBLIQUE THERAPEUTICS AB
公开号:WO2018146469A1
公开(公告)日:2018-08-16
There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.